Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation

NCT07483385 is registered in ClinicalTrials.gov with The General Hospital of Western Theater Command as lead sponsor.

NCT NCT07483385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07483385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
The General Hospital of Western Theater Command
Phase
Not applicable
Overall status
Recruiting
Start date
January 13, 2026
Completion date
January 28, 2028
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic disorders, patients with hematologic disorders after allogeneic hematopoietic stem cell transplantation